• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷胱甘肽S-转移酶P1基因Ile(105)Val多态性与多西他赛诱导的周围神经病变的关系:氧化应激在紫杉烷毒性中作用的临床证据

Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.

作者信息

Mir O, Alexandre J, Tran A, Durand J-P, Pons G, Treluyer J-M, Goldwasser F

机构信息

Department of Medical Oncology, Teaching Hospital Cochin, Université Paris Descartes, Assistance Publique Hôpitaux de Paris, Paris, France.

出版信息

Ann Oncol. 2009 Apr;20(4):736-40. doi: 10.1093/annonc/mdn698. Epub 2009 Feb 17.

DOI:10.1093/annonc/mdn698
PMID:19223573
Abstract

BACKGROUND

Glutathione-S-transferases (GST) regulate the cellular response to oxidative stress. We previously highlighted the importance of oxidative stress in taxane toxicity and therefore investigated the relationship between the GST isoforms M1, T1 and P1 gene polymorphisms and docetaxel (Taxotere)-induced peripheral neuropathy (DIPN).

PATIENTS AND METHODS

The GSTM1 (null), GSTT1 (null) and GSTP1 (Ile(105)Val and Ala(114)Val) polymorphisms were determined in a cohort of cancer patients treated with docetaxel and entered in a clinical trial database. The relationship between GST polymorphisms and grade > or = 2 DIPN as primary end point was studied.

RESULTS

Fifty-eight patients (median age 61 years) received a total of 261 cycles of docetaxel given as single agent. Patients with GSTP1 (105)Ile/(105)Ile genotype had a higher risk of developing a grade > or = 2 DIPN than did those with other GSTP1 genotypes (8 of 27 versus 2 of 31, respectively, odds ratio 6.11; 95% confidence interval 1.17-31.94; P = 0.03). In multivariate analysis, grade > or = 2 DIPN was strongly correlated with GSTP1 (105)Ile/(105)Ile genotype (P = 0.01) and the number of cycles (P = 0.03).

CONCLUSION

We found a significant correlation between GSTP1 (105)Ile/(105)Ile genotype and the development of grade > or = 2 DIPN. This finding strongly suggests a role of oxidative stress in the pathophysiology of DIPN.

摘要

背景

谷胱甘肽 - S - 转移酶(GST)调节细胞对氧化应激的反应。我们之前强调了氧化应激在紫杉烷毒性中的重要性,因此研究了GST同工型M1、T1和P1基因多态性与多西他赛(泰索帝)诱导的周围神经病变(DIPN)之间的关系。

患者与方法

在一组接受多西他赛治疗并录入临床试验数据库的癌症患者中,测定了GSTM1(缺失型)、GSTT1(缺失型)和GSTP1(Ile(105)Val和Ala(114)Val)基因多态性。研究了GST基因多态性与作为主要终点的≥2级DIPN之间的关系。

结果

58例患者(中位年龄61岁)共接受了261个周期的多西他赛单药治疗。GSTP1(105)Ile/(105)Ile基因型患者发生≥2级DIPN的风险高于其他GSTP1基因型患者(分别为27例中的8例和31例中的2例,比值比6.11;95%置信区间1.17 - 31.94;P = 0.03)。在多变量分析中,≥2级DIPN与GSTP1(105)Ile/(105)Ile基因型(P = 0.01)和周期数(P = 0.03)密切相关。

结论

我们发现GSTP1(105)Ile/(105)Ile基因型与≥2级DIPN的发生之间存在显著相关性。这一发现强烈提示氧化应激在DIPN的病理生理学中起作用。

相似文献

1
Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.谷胱甘肽S-转移酶P1基因Ile(105)Val多态性与多西他赛诱导的周围神经病变的关系:氧化应激在紫杉烷毒性中作用的临床证据
Ann Oncol. 2009 Apr;20(4):736-40. doi: 10.1093/annonc/mdn698. Epub 2009 Feb 17.
2
Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer.多西他赛诱导的神经病变:一项针对150名早期乳腺癌女性的药物遗传学病例对照研究。
Acta Oncol. 2015 Apr;54(4):530-7. doi: 10.3109/0284186X.2014.969846. Epub 2014 Nov 10.
3
Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.谷胱甘肽 S-转移酶 (GSTM1、GSTT1、GSTP1) 基因多态性与膀胱癌易感性的关系。
Urol Oncol. 2013 Oct;31(7):1193-203. doi: 10.1016/j.urolonc.2011.11.027. Epub 2011 Dec 11.
4
Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.中国人谷胱甘肽S-转移酶M1和P1的基因型与酶活性之间的关系
Eur J Pharm Sci. 2006 May;28(1-2):77-85. doi: 10.1016/j.ejps.2006.01.002. Epub 2006 Feb 20.
5
Association of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patients.血液透析患者谷胱甘肽-S-转移酶基因多态性与脂蛋白亚类的关联
Clin Biochem. 2014 Apr;47(6):398-403. doi: 10.1016/j.clinbiochem.2013.11.011. Epub 2013 Nov 27.
6
Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer.谷胱甘肽S-转移酶M1、T1、P1基因型与结直肠癌发生风险
Biochem Genet. 2005 Apr;43(3-4):149-63. doi: 10.1007/s10528-005-1508-z.
7
GSTP1 polymorphism among North Indian lung cancer patients treated using monotherapy and poly-pharmacy.印度北部接受单药治疗和多药治疗的肺癌患者 GSTP1 多态性。
Hum Exp Toxicol. 2021 Dec;40(12_suppl):S739-S752. doi: 10.1177/09603271211059496. Epub 2021 Nov 15.
8
Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.谷胱甘肽S-转移酶P1、T1和M1基因多态性与转移性结直肠癌患者生存率的关系。
J Natl Cancer Inst. 2002 Jun 19;94(12):936-42. doi: 10.1093/jnci/94.12.936.
9
Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.谷胱甘肽 S-转移酶基因多态性(GSTM1、GSTT1、GSTP1)与前列腺癌:伊朗德黑兰的病例对照研究。
Prostate Cancer Prostatic Dis. 2011 Jun;14(2):105-13. doi: 10.1038/pcan.2010.54. Epub 2011 Jan 18.
10
Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.谷胱甘肽S-转移酶μ1、θ1、π1、α1和μ3基因多态性与人类结直肠癌和胃癌风险
Pharmacogenomics. 2006 Jul;7(5):711-8. doi: 10.2217/14622416.7.5.711.

引用本文的文献

1
Risk of Cardiovascular Complications Among Type 2 Diabetes Mellitus Patients with GSTP1 Genetic Polymorphism: A Nested Case-Control Study and Docking Studies.2型糖尿病患者中谷胱甘肽S-转移酶P1基因多态性与心血管并发症风险:一项巢式病例对照研究及对接研究
Biochem Genet. 2024 May 27. doi: 10.1007/s10528-024-10823-4.
2
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.厄瑞布林在未选择的转移性乳腺癌女性患者中的耐受性和与神经病变的相关性:多中心、单臂、IV 期 PAINTER 研究的结果。
Breast Cancer Res. 2022 Oct 28;24(1):71. doi: 10.1186/s13058-022-01560-w.
3
Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity.
个体化医学时代的副作用管理:化疗诱导的周围神经毒性。
Methods Mol Biol. 2022;2547:95-140. doi: 10.1007/978-1-0716-2573-6_5.
4
Neuroprotective Effect of Natural Compounds in Paclitaxel-Induced Chronic Inflammatory Pain.天然化合物在紫杉醇诱导的慢性炎症性疼痛中的神经保护作用。
Molecules. 2022 Aug 2;27(15):4926. doi: 10.3390/molecules27154926.
5
Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark.单核苷酸多态性与基于紫杉烷的化疗在绝经前乳腺癌中的疗效:丹麦基于人群的队列研究。
Breast Cancer Res Treat. 2022 Jul;194(2):353-363. doi: 10.1007/s10549-022-06596-2. Epub 2022 Apr 30.
6
Association between Genetic Polymorphism of GSTP1 and Toxicities in Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.GSTP1基因多态性与接受铂类化疗患者毒性反应之间的关联:一项系统评价和Meta分析
Pharmaceuticals (Basel). 2022 Apr 1;15(4):439. doi: 10.3390/ph15040439.
7
An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report).一例 HR+/HER2+ 长生存乳腺癌患者的个体化治疗(病例报告)。
Curr Oncol. 2021 May 25;28(3):1980-1987. doi: 10.3390/curroncol28030184.
8
Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas.低级别化疗引起的周围神经病变(CINP)与胰腺转移性腺癌患者生存率之间的关联
J Clin Med. 2021 Apr 23;10(9):1846. doi: 10.3390/jcm10091846.
9
Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships.通过评估直接遗传药理学-药代动力学和药代动力学-神经病变关系,探索紫杉醇和多西紫杉醇诱导的周围神经病的药物遗传学。
Expert Opin Drug Metab Toxicol. 2021 Feb;17(2):227-239. doi: 10.1080/17425255.2021.1856367. Epub 2021 Jan 6.
10
Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms.DPYD和GSTP1基因多态性对氟嘧啶和奥沙利铂化疗在结直肠癌中临床毒性的预测价值
World J Surg Oncol. 2020 Dec 6;18(1):321. doi: 10.1186/s12957-020-02103-3.